Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$125645.00
↑ 105% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-2.66M
Historical baseline
PeriodValueYoY Change
TTM$125645.00+102.9%
2024$-4.29M+53.0%
2023$-9.13M-
2022$0.00-
2021$0.00-